Business
Pet Service Holding Reports Full Year 2025 Revenue up +7.7% to €13.6 Million
ZAANSTAD, Netherlands, January 30, 2026--Regulatory News: Pet Service Holding NV (Euronext Growth Paris, ISIN: NL0015001HZ9 / Ticker: ALPET), active in the European market for veterinary products, animal healthcare, and premium pet supplies (the "Company" or "PSH"), today announces its full year 2025 revenue up +7.7% to €13.6 million.
About this update from Pet Service Holding N.v
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1024,"height":512,"url":"https://media.zenfs.com/en/business-wire.com/13a29b9a0a24e1aecd7d409db7951729"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/hVDXqQiFOq.b8QstneEPaw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/13a29b9a0a24e1aecd7d409db7951729","width":960,"height":480},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/7gHoBH5NOpp9Ea0ljMUJLw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNDg7aD0xMDI0O2NmPXdlYnA-/https://media.zenfs.com/en/business-wire.com/13a29b9a0a24e1aecd7d409db7951729","width":1024,"height":512}},"lazy":false},{"type":"text","content":"ZAANSTAD, Netherlands, January 30, 2026--(BUSINESS WIRE)--Regulatory News:","length":74,"tagName":"p"},{"type":"text","content":"Pet Service Holding NV (Euronext Growth Paris, ISIN: NL0015001HZ9 / Ticker: ALPET), active in the European market for veterinary products, animal healthcare, and premium pet supplies (the "Company" or "PSH"), today announces its full year 2025 revenue up +7.7% to €13.6 million.","length":298,"tagName":"p"},{"type":"text","content":"Full-Year 2025 Revenue","length":22,"tagName":"p"},{"type":"text","content":"In 2025, PSH recorded revenue of €13.6 million1, up +7.7% compared to 2024. The Company delivered a solid growth in the first half of 2025, with revenue reaching €7.0 million, representing a substantial +14% year-on-year increase driven by both its online consumer platforms and wholesale activities, reflecting the successful execution of PSH’s strategy.","length":355,"tagName":"p"},{"type":"text","content":"Revenue in the second half of 2025 amounted to €6.5 million, in a moderate progression (+3% year-on-year), mainly due to the Duch regulatory requirements which led PSH to discontinue the sale of certain prescription-only veterinary medicines outside the Netherlands during the fourth quarter of 2025.","length":300,"tagName":"p"},{"type":"text","content":"As explained in PSH’s previous communications2 this decision followed the information from the Dutch Food and Consumer Product Safety Authority (NVWA) stating that certain UDA-classified veterinary medicines, subject to medical prescription, may not be offered online in EU member states other than ...